Literature DB >> 22700887

Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.

Rin Asao1, Katsuhiko Asanuma, Fumiko Kodama, Miyuki Akiba-Takagi, Yoshiko Nagai-Hosoe, Takuto Seki, Yukihiko Takeda, Isao Ohsawa, Satoshi Mano, Kiyoshi Matsuoka, Hiroyuki Kurosawa, Shinya Ogasawara, Yoshiaki Hirayama, Sakari Sekine, Satoshi Horikoshi, Masanori Hara, Yasuhiko Tomino.   

Abstract

BACKGROUND AND OBJECTIVES: Podocalyxin (PCX) is present on the apical cell membrane of podocytes and is shed in urine from injured podocytes. Urinary podocalyxin (u-PCX) is associated with severity of active glomerular injury in patients with glomerular diseases. This study examined the relationship between number of urinary podocytes, levels of u-PCX, and glomerular injury in adults with IgA nephropathy (IgAN). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Urine samples voided in the morning on the day of biopsy were obtained from 51 patients with IgAN (18 men and 33 women; mean age, 31 years). All renal biopsy specimens were analyzed histologically. Pathologic variables of IgAN were analyzed per Shigematsu classification, the Oxford classification of IgAN, and the Clinical Guidelines of IgAN in Japan. Levels of u-PCX were measured by sandwich ELISA.
RESULTS: Histologic analysis based on Shigematsu classification revealed a significant correlation between levels of u-PCX and severity of acute extracapillary abnormalities (r=0.72; P<0.001), but levels of urinary protein excretion did not correlate with acute glomerular abnormalities. Levels of urinary protein excretion in patients with segmental sclerosis (n=19) were higher than in patients without (n=22) (0.49 [interquartile range (IQR), 0.20-0.88] g/g creatinine versus 0.20 [IQR, 0.10-0.33] g/g creatinine; P<0.01). The number of urinary podocytes in patients with segmental sclerosis was higher than in patients without (1.05 [IQR, 0.41-1.67] per mg creatinine versus 0.28 [IQR, 0.10-0.66] per mg creatinine; P<0.01).
CONCLUSIONS: Levels of u-PCX and the number of urinary podocytes are associated with histologic abnormalities in adults with IgAN.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22700887      PMCID: PMC3430952          DOI: 10.2215/CJN.08110811

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  36 in total

1.  Molecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxin.

Authors:  D B Kershaw; S G Beck; B L Wharram; J E Wiggins; M Goyal; P E Thomas; R C Wiggins
Journal:  J Biol Chem       Date:  1997-06-20       Impact factor: 5.157

2.  Monoclonal antibodies to the large glycoproteins of respiratory syncytial virus: possible evidence for several functional antigenic sites.

Authors:  H Tsutsumi; T D Flanagan; P L Ogra
Journal:  J Gen Virol       Date:  1987-08       Impact factor: 3.891

Review 3.  Histological grading and staging of IgA nephropathy.

Authors:  H Shigematsu
Journal:  Pathol Int       Date:  1997-04       Impact factor: 2.534

4.  Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis.

Authors:  M Hara; T Yanagihara; T Takada; M Itoh; M Matsuno; T Yamamoto; I Kihara
Journal:  Am J Nephrol       Date:  1998       Impact factor: 3.754

5.  Identification of a major sialoprotein in the glycocalyx of human visceral glomerular epithelial cells.

Authors:  D Kerjaschki; H Poczewski; G Dekan; R Horvat; E Balzar; N Kraft; R C Atkins
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

6.  Corticosteroids in IgA nephropathy: a randomised controlled trial.

Authors:  C Pozzi; P G Bolasco; G B Fogazzi; S Andrulli; P Altieri; C Ponticelli; F Locatelli
Journal:  Lancet       Date:  1999-03-13       Impact factor: 79.321

Review 7.  Progression of glomerular diseases: is the podocyte the culprit?

Authors:  W Kriz; N Gretz; K V Lemley
Journal:  Kidney Int       Date:  1998-09       Impact factor: 10.612

8.  Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury.

Authors:  Masanori Hara; Toshio Yanagihara; Itaru Kihara; Kazuhiro Higashi; Kotarou Fujimoto; Tadahiro Kajita
Journal:  J Am Soc Nephrol       Date:  2004-12-29       Impact factor: 10.121

9.  Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials.

Authors:  Joshua A Samuels; Giovanni F M Strippoli; Jonathan C Craig; Francesco P Schena; Donald A Molony
Journal:  Nephrology (Carlton)       Date:  2004-08       Impact factor: 2.506

10.  Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial.

Authors:  Claudio Pozzi; Simeone Andrulli; Lucia Del Vecchio; Patrizia Melis; Giovanni B Fogazzi; Paolo Altieri; Claudio Ponticelli; Francesco Locatelli
Journal:  J Am Soc Nephrol       Date:  2004-01       Impact factor: 10.121

View more
  31 in total

Review 1.  Biomarkers in IgA nephropathy: relationship to pathogenetic hits.

Authors:  Margaret Colleen Hastings; Zina Moldoveanu; Hitoshi Suzuki; Francois Berthoux; Bruce A Julian; John T Sanders; Matthew B Renfrow; Jan Novak; Robert J Wyatt
Journal:  Expert Opin Med Diagn       Date:  2013-11

2.  Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases.

Authors:  Larysa Wickman; Farsad Afshinnia; Su Q Wang; Yan Yang; Fei Wang; Mahboob Chowdhury; Delia Graham; Jennifer Hawkins; Ryuzoh Nishizono; Marie Tanzer; Jocelyn Wiggins; Guillermo A Escobar; Bradley Rovin; Peter Song; Debbie Gipson; David Kershaw; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2013-09-19       Impact factor: 10.121

3.  Urine podocyte mRNAs mark disease activity in IgA nephropathy.

Authors:  Akihiro Fukuda; Yuji Sato; Takashi Iwakiri; Hiroyuki Komatsu; Masao Kikuchi; Kazuo Kitamura; Roger C Wiggins; Shouichi Fujimoto
Journal:  Nephrol Dial Transplant       Date:  2015-05-08       Impact factor: 5.992

4.  Urinary Podocyte Biomarkers and Glomerular Histologic Change.

Authors:  Kazunori Inoue
Journal:  Kidney360       Date:  2022-01-20

5.  Expression patterns of podocyte-associated mRNAs in patients with proliferative or non-proliferative glomerulopathies.

Authors:  Patrícia Garcia Rodrigues; Rafael Nazário Bringhenti; Jonathan Frapporti do Nascimento; Gabriel Joelsons; Mariane dos Santos; Sane Pereira; Francisco Veríssimo Veronese
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

6.  Urinary and glomerular podocytes in patients with chronic kidney diseases.

Authors:  Kikuno Hanamura; Akihiro Tojo; Toshiro Fujita
Journal:  Clin Exp Nephrol       Date:  2013-05-15       Impact factor: 2.801

Review 7.  Markers for the progression of IgA nephropathy.

Authors:  Dita Maixnerova; Colin Reily; Qi Bian; Michaela Neprasova; Jan Novak; Vladimir Tesar
Journal:  J Nephrol       Date:  2016-05-03       Impact factor: 3.902

8.  Dual involvement of growth arrest-specific gene 6 in the early phase of human IgA nephropathy.

Authors:  Kojiro Nagai; Masashi Miyoshi; Takei Kake; Naoshi Fukushima; Motokazu Matsuura; Eriko Shibata; Satoshi Yamada; Kazuhiro Yoshikawa; Hiro-Omi Kanayama; Tomoya Fukawa; Kunihisa Yamaguchi; Hirofumi Izaki; Akira Mima; Naoko Abe; Toshikazu Araoka; Taichi Murakami; Fumi Kishi; Seiji Kishi; Tatsuya Tominaga; Tatsumi Moriya; Hideharu Abe; Toshio Doi
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

9.  Synergistic effect of mesangial cell-induced CXCL1 and TGF-β1 in promoting podocyte loss in IgA nephropathy.

Authors:  Li Zhu; Qingxian Zhang; Sufang Shi; Lijun Liu; Jicheng Lv; Hong Zhang
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

Review 10.  A compendium of urinary biomarkers indicative of glomerular podocytopathy.

Authors:  Miroslav Sekulic; Simona Pichler Sekulic
Journal:  Patholog Res Int       Date:  2013-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.